Changes in insulin secretion and glucose metabolism induced by dexamethasone in lean and obese females.
OBJECTIVE
In healthy lean individuals, changes in insulin sensitivity occurring as a consequence of a 2-day dexamethasone administration are compensated for by changes in insulin secretion, allowing glucose homeostasis to be maintained. This study evaluated the changes in glucose metabolism and insulin secretion induced by short-term dexamethasone administration in obese women.


METHODS
Eleven obese women with normal glucose tolerance were studied on two occasions, without and after 2 days of low-dose dexamethasone administration. A two-step hyperglycemic clamp (7.5 and 10 mM glucose) with 6,6 (2)H(2) glucose was used to assess insulin secretion and whole body glucose metabolism. Results were compared with those obtained in a group of eight lean women.


RESULTS
Without dexamethasone, obese women had higher plasma insulin concentrations in the fasting state, during the first phase of insulin secretion, and at the two hyperglycemic plateaus. However, they had normal whole body glucose metabolism compared with lean women, indicating adequate compensation. After dexamethasone, obese women had a 66% to 92% increase in plasma insulin concentrations but a 15.4% decrease in whole body glucose disposal. This contrasted with lean women, who had a 91% to 113% increase in plasma insulin concentrations, with no change in whole body glucose disposal.


CONCLUSIONS
Dexamethasone administration led to a significant reduction in whole body glucose disposal at fixed glycemia in obese but not lean women. This indicates that obese women are unable to increase their insulin secretion appropriately.
Besse
Christine
C
Department of Physiology, University of Lausanne, Switzerland.
Nicod
Nathalie
N
Tappy
Luc
L
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D003903:Deuterium; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D005947:Glucose / Q000378:metabolism*; D015309:Glucose Clamp Technique; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D015227:Lipid Peroxidation; D009765:Obesity / Q000503:physiopathology*; D010084:Oxidation-Reduction
D001786:Blood Glucose; D007328:Insulin; D003907:Dexamethasone; D003903:Deuterium; D005947:Glucose; D006854:Hydrocortisone